Food And Drug Administration-Healthday News-Breast Cancer-Everolimus-Afinitor

Afinitor Approved for Advanced Breast Cancer

FRIDAY, July 20 (Healthday News) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration said Friday. read more..

source:http://yhoo.it/OM3q3V

Food And Drug Administration-Tuberous Sclerosis Complex-Healthday News-Kidney Tumors

Afinitor Approval Expanded to Include Benign Kidney Tumors

FRIDAY, April 27 (Healthday News) -- Afinitor (everolimus) is the first drug to be approved by the U.S. Food And Drug Administration to treat benign kidney tumors among people with a rare genetic condition called tuberous sclerosis complex (TSC), the agency said in a news release. read more..

source:http://yhoo.it/J7n2eT